There is currently insufficient evidence to recommend screening of kidney allograft donors and recipients for parvovirus B19 infection. As such, physicians managing recipients need to have a high index of suspicion, and include this type of infection in their differential diagnosis of chronic anemia and other cytopenias in the post-transplantation period. Here, Waldman and Kopp from the NIH review the pathogenesis, diagnosis and management of parvovirus B19 infection.
- Meryl Waldman
- Jeffrey B Kopp
